Back to search
FDAFDA · Food and drugs·Recall number D-0006-2015

Xarelto (rivaroxaban) Tablets 15 mg per tablet, 5 count bottle, Rx Only, Manufactured by: JOLLC, Gurabo, PR 00778 NDC 50458-578-99

Published October 15, 2014 · Recall initiated: September 17, 2014

Summary

FDA records drug Class II recall D-0006-2015, published October 15, 2014 and initiated September 17, 2014. Recalling firm: Janssen Ortho L.L.C.; Status: Terminated; Reported quantity: 13500 bottles; Lot: Lot 13JG2616 Exp. 07/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microbial Contamination of Non-Sterile Products: Consumer complaint confirmed microbial contamination in sales sample.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Janssen Ortho L.L.C.
Distributor
Nationwide
Lot
Lot 13JG2616 Exp. 07/16
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Xarelto (rivaroxaban) Tablets 15 mg per tablet, 5 count bottle, Rx Only, Manufactured by: JOLLC, Gurabo, PR 00778 NDC 50458-578-99 recalled?

Yes. FDA published recall D-0006-2015 on October 15, 2014. Reported hazard: Microbial Contamination of Non-Sterile Products: Consumer complaint confirmed microbial contamination in sales sample.

What should I do if I have this product?

Voluntary: Firm initiated · Letter